Melanocytic naevi, other sites/unspecified

CD2_BENIGN_MELANOCYTIC_NOS

brain neoplasm: A neoplasm (disease) that involves the brain.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.9& Hospital discharge: ICD-9 — 216[8-9]A Cause of death: ICD-10 — D22.9& Cause of death: ICD-9 — 216[8-9]A 2 out of 7 registries used, show all original rules.	3117
4. Check minimum number of events None	3117
5. Include endpoints None	3117
6. Filter based on genotype QC (FinnGen only)	3117

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus non specificatus

NAME	CD2_BENIGN_MELANOCYTIC_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D229
HD_ICD_9	216[8-9]A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D229
COD_ICD_9	216[8-9]A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi, other sites/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Melanocytic naevi, other sites/unspecified

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17921	10632	7232
Only index persons	17173	10310	6863
Unadjusted period prevalence (%)
Whole population	0.26	0.30	0.20
Only index persons	0.33	0.38	0.26
Median age at first event (years)
Whole population	46.63	44.10	50.35
Only index persons	46.96	44.28	50.98

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3117	1925	1192
Unadjusted period prevalence (%)	0.61	0.66	0.53
Median age at first event (years)	53.48	48.97	60.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2774: Matched controls
27741

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

5603.7

323.0

2739

430

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

11.4

323.0

759

890

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

10.6

323.0

864

1139

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

9.6

267.9

591

757

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

7.4

232.6

613

1026

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

15.0

178.0

307

228

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

10.9

148.5

297

301

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

303.0

141.8

143

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

6.5

141.5

399

700

XQ845

NOMESCO Finland

Dermatoscopy

21.7

139.2

208

103

L57.0

ICD-10 Finland

Actinic keratosis

5.3

135.3

455

989

L82

ICD-10 Finland

Seborrhoeic keratosis

3.6

121.4

632

2076

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

31.6

120.2

161

XQ848

NOMESCO Finland

Dermatological photography

10.3

119.1

245

259

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

10.0

111.5

232

250

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

11.8

99.2

189

171

R23.8

ICD-10 Finland

Other and unspecified skin changes

3.1

94.6

606

2276

SPAT1153

SPAT

Removal of sutures

2.4

90.9

1038

5490

127

Kela drug reimbursment

Transplant complication

12.3

85.6

159

136

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

9.1

84.7

185

216

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

20.3

78.5

119

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

4.8

74.8

265

592

L04AA06

ATC

mycophenolic acid; systemic

10.2

73.9

151

156

Z94.0

ICD-10 Finland

Kidney transplant status

15.3

72.5

122

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

9.1

72.3

157

181

ZXC50

NOMESCO Finland

Cryotherapy

7.3

69.5

174

252

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

21.8

68.3

101

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

24.8

67.6

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

19.7

64.8

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

22.6

64.3

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

7.9

58.8

139

184

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

18.6

57.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

16.2

57.4

PJA12

NOMESCO Finland

Sentinel node biopsy

3.4

57.2

298

938

S18

ICPC

Laceration/cut

1.9

54.6

1174

7682

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

14.8

50.7

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

9.0

50.6

110

127

L04AD01

ATC

ciclosporin; systemic

7.0

48.6

124

184

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.1

48.5

123

181

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

3.8

48.0

216

601

S82

ICPC

Naevus/mole

2.5

45.9

406

1787

TQW99

NOMESCO Finland

Other minor procedure on skin

3.9

44.6

192

514

137

Kela drug reimbursment

Uraemia requiring dialysis

12.4

44.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

19.9

43.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.9

41.7

121

214

D03.5

ICD-10 Finland

Melanoma in situ of trunk

23.7

40.6

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

5.3

37.0

116

225

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

7.6

36.6

117

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

5.2

35.6

114

227

ZZR00

NOMESCO Finland

Flap of skin

5.9

35.4

102

179

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

15.0

35.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.1

34.9

204

693

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

4.9

34.7

117

247

TQW80

NOMESCO Finland

Local dermatologic skincare

4.6

34.5

125

284

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

5.1

34.1

111

225

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

36.4

33.7

TK800

NOMESCO Finland

Hemodialysis

5.5

33.5

102

192

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

12.2

33.4

B05DA

ATC

Isotonic solutions

12.2

33.4

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

23.9

33.1

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

23.9

33.1

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

21.2

32.6

L04AA01

ATC

[U] ciclosporin; systemic

7.1

32.5

117

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.0

32.3

106

217

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

43.9

31.9

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

15.7

31.2

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

39.6

31.2

A12AA04

ATC

calcium carbonate; oral

6.1

30.6

143

D22

ICD-10 Finland

Melanocytic naevi

3.2

30.1

170

562

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

12.2

29.7

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

50.6

29.4

E0000UV

ATC

1.6

29.4

1069

7762

L04AX01

ATC

azathioprine; systemic

3.2

28.5

156

506

B03XA02

ATC

darbepoetin alfa; parenteral

5.9

27.5

135

A11CC03

ATC

alfacalcidol; systemic

4.5

26.9

220

B07.9

ICD-10 Finland

Verruca simplex

3.5

26.5

127

373

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

9.3

26.4

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

19.8

26.1

B05DB

ATC

Hypertonic solutions

11.1

25.8

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.1

25.6

ZXC15

NOMESCO Finland

Use of photodynamic technique

6.6

25.4

102

Z49.2

ICD-10 Finland

Other dialysis

9.4

25.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

6.1

25.1

115

SPAT1312

SPAT

General health counselling

1.6

25.1

879

6252

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.8

25.1

127

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

24.7

1032

7654

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

16.5

24.5

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.7

24.2

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

4.3

24.1

222

2168A

ICD-9 Finland

Benign neoplasm of skin, Other specified sites of skin[IHON BEN KASV MUUALLA,NAEVUS PIGMENTOSUS]

+∞

24.0

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

17.8

23.9

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

11.1

23.9

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.2

23.6

266

1295

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

18.6

23.0

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

22.9

200

863

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

21.6

22.1

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.8

21.4

253

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

6.5

20.8

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

8.9

20.8

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.8

20.5

101

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

14.3

20.3

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

4.4

20.1

173

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

10.4

20.1

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

9.2

19.8

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

16.5

19.6

H02AB04

ATC

methylprednisolone; systemic

1.8

19.6

367

2168

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

15.7

19.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

19.2

714

5089

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.7

19.1

133

506

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.6

19.0

138

539

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

19.0

848

6292

V03AE02

ATC

sevelamer; oral

10.7

18.9

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

18.8

345

2020

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

16.3

18.3

C43

ICD-10 Finland

Malignant melanoma of skin

17.7

18.2

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

6.7

18.1

N18.8

ICD-10 Finland

Other chronic renal failure

3.5

18.0

248

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

18.0

456

2940

SPAT1325

SPAT

Vaccination

1.5

17.9

801

5931

R4180

NOMESCO Finland

Podiatric therapy

7.0

17.9

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

26.9

17.8

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

22.9

17.7

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

17.7

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

7.5

17.6

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.1

17.6

109

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

17.6

154

667

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.9

17.3

106

373

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

3.8

17.0

198

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.2

16.9

283

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

5.6

16.9

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

19.4

16.9

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

63.7

16.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

8.5

16.7

180

Kela drug reimbursment

Interferon alfa

12.7

16.6

D06BB10

ATC

imiquimod; topical

2.4

16.6

139

589

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

90.6

16.6

J01DB01

ATC

cefalexin; oral

1.5

16.5

2153

19447

Z94.1

ICD-10 Finland

Heart transplant status

18.0

16.4

TK820

NOMESCO Finland

Peritoneal dialysis

10.8

16.4

UJF32

NOMESCO Finland

Coloscopy

1.5

16.4

593

4174

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

9.0

16.4

SPAT1301

SPAT

No procedures

1.5

16.3

759

5647

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

16.2

402

2570

N02BE01

ATC

paracetamol; systemic, rectal

1.5

16.1

2212

20124

D22.0

ICD-10 Finland

Melanocytic naevi of lip

16.8

16.1

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

47.8

16.0

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

47.8

16.0

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

13.0

15.6

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

7.6

15.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.0

15.4

B03XA01

ATC

erythropoietin; parenteral

6.6

15.4

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.1

15.1

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

11.3

14.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

5.6

14.6

205

Kela drug reimbursment

Chronic hypertension

1.5

14.6

537

3781

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

4.5

14.6

115

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

14.5

517

3619

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.9

14.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

14.3

142

652

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

14.1

310

1913

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

8.0

14.0

C03CA01

ATC

furosemide; systemic

1.5

13.9

516

3634

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.1

13.9

166

829

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

30.2

13.9

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

17.6

13.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.3

13.7

118

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

13.7

645

4781

C02AC05

ATC

moxonidine; oral

2.5

13.6

110

458

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

13.5

992

7974

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

7.5

13.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

13.3

715

5429

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

21.2

13.3

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

7.0

13.3

C08CA02

ATC

felodipine; oral

1.9

13.3

190

1018

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

13.3

247

1448

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

5.6

13.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

13.1

148

722

Z31.5

ICD-10 Finland

Genetic counselling

2.2

13.0

138

656

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

16.8

13.0

S77

ICPC

Malignant neoplasm of skin

4.8

13.0

9733

FHL

Excision of skin change in operating room or anesthesia

4.1

12.9

120

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

12.9

220

1254

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.8

973

7847

N18.0

ICD-10 Finland

End-stage renal disease

4.6

12.8

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

7.2

12.7

SPAT1263

SPAT

Sampling

1.4

12.7

1040

8492

ZZA00

NOMESCO Finland

Split skin graft

2.9

12.6

262

L01EC02

ATC

dabrafenib; oral

70.2

12.6

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

5.1

12.6

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

32.2

12.6

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

32.2

12.6

L91.0

ICD-10 Finland

Hypertrophic scar

3.9

12.5

129

V03AE01

ATC

polystyrene sulfonate; oral

4.9

12.5

C08CA13

ATC

lercanidipine; oral

1.7

12.5

268

1642

ICD-10 Finland

3.0

12.4

240

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

11.7

12.3

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

10.5

12.2

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

15.9

12.1

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

8.7

12.0

QXA05

NOMESCO Finland

Skin division, unspecified location

9.3

12.0

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

11.9

279

1750

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

13.4

11.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

11.7

525

3837

L04AA05

ATC

[U] tacrolimus; systemic

30.1

11.6

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

30.1

11.6

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.3

11.5

181

2169A

ICD-9 Finland

Benign neoplasm of skin, Skin, site unspecified[IHON BEN KASV,NUD,NAEVUS PIGMENTOSUS]

+∞

11.5

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.7

11.3

JAL10

NOMESCO Finland

Laparotomy and removal of foreign body

35.2

11.3

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

11.2

116

545

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

9.6

11.2

SPAT1260

SPAT

Consultation of another employee

1.5

11.2

410

2874

L01XE23

ATC

[U] dabrafenib; oral

25.1

11.1

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

12.7

11.1

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

20.1

11.1

C02CA01

ATC

prazosin; oral

4.1

11.1

104

A98

ICPC

Health maint/preventive medicine

1.8

11.1

2636

25381

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.9

11.0

170

940

J01MA02

ATC

ciprofloxacin; systemic

1.3

10.9

858

6914

S15

ICPC

Foreign body in skin

2.0

10.9

145

758

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

4.1

10.8

102

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

10.8

131

659

S29

ICPC

Skin symptom/complaint other

1.5

10.7

374

2591

L01EE01

ATC

trametinib; oral

60.2

10.6

SPAT1324

SPAT

Screening procedure

1.4

10.6

471

3434

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

10.6

618

4736

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

11.2

10.5

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

10.5

1260

10788

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

10.3

186

1081

R01AD09

ATC

mometasone; nasal

1.3

10.3

1103

9291

V03AE03

ATC

lanthanum carbonate; oral

8.8

10.3

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

10.2

862

7008

H02AB09

ATC

hydrocortisone; systemic

2.9

10.2

216

J01FA10

ATC

azithromycin; systemic

1.3

10.2

1473

12922

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

6.2

10.1

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.6

10.1

289

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

14.6

10.0

D06BX01

ATC

metronidazole; topical

1.6

10.0

247

1574

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

5.1

10.0

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

9.9

783

6293

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

9.8

267

1742

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

9.8

178

1037

R50.9

ICD-10 Finland

Fever, unspecified

1.5

9.8

311

2107

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

26.1

9.8

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

9.8

143

TFJ02

NOMESCO Finland

Muscle biopsy of heart

9.6

9.7

ZXA00

NOMESCO Finland

Right side

1.4

9.7

569

4353

ZXA05

NOMESCO Finland

Left side

1.4

9.7

534

4042

D07AC01

ATC

betamethasone; topical

1.3

9.4

777

6279

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

9.4

833

6801

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

30.1

9.4

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

9.4

419

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

21.8

9.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

4.7

9.3

A02BC05

ATC

esomeprazole; systemic

1.3

9.3

906

7502

ZZA50

NOMESCO Finland

Full thickness skin graft

6.4

9.2

D02AE01

ATC

carbamide; topical

1.8

9.2

162

936

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

9.2

249

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.4

9.2

304

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

13.7

9.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

9.2

158

908

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.5

9.2

282

1898

C07AB02

ATC

metoprolol; systemic

1.5

9.1

382

2745

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.1

945

7881

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

9.1

609

4762

J01CA04

ATC

amoxicillin; systemic

1.3

9.1

2093

19397

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

6.3

9.1

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

5.1

9.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.2

9.0

A02BC02

ATC

pantoprazole; systemic

1.3

9.0

1516

13467

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.0

276

1856

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

18.6

8.9

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

24.1

8.9

J05AB01

ATC

aciclovir; systemic

1.4

8.9

473

3556

D01AE16

ATC

amorolfine; topical

1.6

8.8

240

1568

QBA10

NOMESCO Finland

Incision of skin of trunk

3.5

8.8

112

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

8.6

8.8

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.7

641

5083

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

8.7

386

2805

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

8.7

294

2021

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

50.1

8.7

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.6

8.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

5.8

8.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.6

701

5646

4056

NOMESCO Finland

16.3

8.5

C09CA01

ATC

losartan; oral

1.4

8.5

468

3536

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

3.0

8.5

154

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

8.5

141

801

L01XE25

ATC

[U] trametinib; oral

27.6

8.5

ZX120

NOMESCO Finland

Intravenous

1.6

8.5

203

1282

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

8.5

177

1076

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

6.0

8.4

L03AB05

ATC

interferon alfa-2b; parenteral

7.3

8.4

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

90.3

8.4

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.4

8.3

113

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

10.8

8.3

Z94.2

ICD-10 Finland

Lung transplant status

10.8

8.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

8.3

493

3774

H05BX01

ATC

cinacalcet; oral

5.8

8.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.8

8.3

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.0

8.3

146

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

14.5

8.2

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

6.5

8.2

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.2

8.1

351

SPAT1310

SPAT

Counselling related to known health issue

1.3

8.1

728

5935

5AB14

NOMESCO Finland

11.7

8.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.0

1631

14737

C03DA01

ATC

spironolactone; oral

1.6

7.9

201

1292

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

10.8

7.8

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

7.8

675

5472

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

3.5

7.8

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.5

7.8

E000001

ATC

1.4

7.7

470

3609

J02AC01

ATC

fluconazole; systemic

1.3

7.7

959

8149

Z80.9

ICD-10 Finland

Family history of malignant neoplasm, unspecified

45.1

7.7

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

15.0

7.7

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

7.7

220

L85.89

ICD-10 Finland

Other specified epidermal thickening

11.9

7.6

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

11.9

7.6

602

Kela drug reimbursment

Children's severe malnutrition

11.9

7.6

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.3

7.5

C08CA01

ATC

amlodipine; oral

1.3

7.5

668

5432

A02BC01

ATC

omeprazole; systemic

1.3

7.5

577

4595

C10AA03

ATC

pravastatin; oral

1.8

7.5

132

765

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.2

7.4

118

C43.80

ICD-10 Finland

Overall malignant melanoma of the skin without histology

80.3

7.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

7.4

799

6661

ZXD05

NOMESCO Finland

Urgent procedure

1.3

7.4

709

5820

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

6.0

7.4

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

4.1

7.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

7.3

303

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.3

164

1021

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.3

958

8182

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

7.2

110

609

HA1AA

NOMESCO Finland

X-ray mammography

1.7

7.2

150

913

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

7.2

223

1506

C07AG02

ATC

carvedilol; oral

1.8

7.2

113

633

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

7.2

111

618

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

30.1

7.1

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

20.1

7.1

D07AD01

ATC

clobetasol; topical

1.4

7.1

326

2381

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

7.9

7.1

B35.3

ICD-10 Finland

Tinea pedis

2.0

7.1

437

7151

FHL

Kidney transplantation

12.0

7.1

UKC02

NOMESCO Finland

Cystoscopy

1.4

7.1

300

2161

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

7.1

1768

16226

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

8.8

7.0

QDH05

NOMESCO Finland

Correction of deformity of toe nail

8.8

7.0

ZX108

NOMESCO Finland

Inhalation

4.3

7.0

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.8

7.0

110

616

L84

ICD-10 Finland

Corns and callosities

2.1

7.0

355

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

7.0

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

7.0

225

1532

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

7.0

169

1076

C09AA02

ATC

enalapril; systemic

1.4

6.9

359

2684

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

5.8

6.9

XKD00

NOMESCO Finland

Uroflowmetry

1.4

6.9

291

2092

J05AB11

ATC

valaciclovir; oral

1.4

6.9

279

1993

J01DA01

ATC

[U] cefalexin; systemic

1.2

6.8

1508

13621

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.0

6.8

402

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.8

6.8

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.7

6.8

156

C43.74

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip acral

40.1

6.8

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

40.1

6.8

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

16.7

6.7

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

16.7

6.7

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

16.7

6.7

S21

ICPC

Skin texture symptom/complaint

1.5

6.7

253

1778

-54

ICPC

Repair/fix-suture/cast/prosth device

2.3

6.7

249

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

6.7

127

757

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

6.7

145

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

22.6

6.7

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.6

6.7

C02EA02

ATC

2.0

6.7

387

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.0

6.7

117

L85.3

ICD-10 Finland

Xerosis cutis

3.8

6.7

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

3.0

6.6

123

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

6.6

242

1692

B01AB05

ATC

enoxaparin; parenteral

1.3

6.6

615

5018

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.7

6.6

163

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

12.3

6.6

S19

ICPC

Skin injury other

2.0

6.6

422

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

6.5

505

4017

R01AD12

ATC

fluticasone furoate; nasal

1.3

6.5

693

5748

DAB10

NOMESCO Finland

Partial excision of auricle

10.0

6.5

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.8

6.5

Z00.0

ICD-10 Finland

General medical examination

1.4

6.5

401

3085

N63

ICD-10 Finland

Unspecified lump in breast

1.7

6.5

133

808

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

6.2

6.5

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

6.5

233

1625

C43.92

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin: 'superficial spreading' type

70.0

6.4

D18.0

ICD-10 Finland

Haemangioma, any site

2.3

6.4

230

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

7.4

6.4

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

6.4

115

673

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

6.4

424

3300

D06BX02

ATC

ingenol mebutate; topical

3.2

6.3

S59

ICPC

Skin, Other therap proced/minor surg NEC

3.2

6.3

K50.8

ICD-10 Finland

Other Crohn disease

2.6

6.3

169

A12BA01

ATC

potassium chloride; oral

2.0

6.3

347

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.6

6.3

VALMI

NOMESCO Finland

1.3

6.3

576

4689

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

18.0

6.3

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

18.0

6.3

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.2

643

5313

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

6.2

281

2045

B35.1

ICD-10 Finland

Tinea unguium

1.7

6.2

121

726

ZQZ00

NOMESCO Finland

Treatment of several skin areas

4.8

6.2

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

7.0

6.2

JN4AD

NOMESCO Finland

Body CT examination

1.6

6.2

139

869

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.2

6.2

256

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

6.1

211

1459

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

6.1

517

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

6.1

489

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

6.1

841

7193

C08CA05

ATC

nifedipine; systemic

1.7

6.1

116

693

R06AE07

ATC

cetirizine; oral

1.2

6.1

1013

8843

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.3

6.1

247

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

4.9

6.0

GDG10

NOMESCO Finland

Bilateral transplantation of lung

10.0

6.0

EMB10

NOMESCO Finland

Tonsillectomy

1.6

6.0

137

859

ZXA10

NOMESCO Finland

Bilateral

1.4

6.0

362

2771

P15

ICPC

Chronic alcohol abuse

0.2

6.0

309

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

1860

10454

2.93

183.91

3.0

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

157

150

10.97

144.31

1.2

1.6

ug/l

6.4

8.1

0.57

151

128

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

105

19.37

133.90

1.0

1.9

ug/l

1.8

0.01

(3002256) Pathology report gross observation

712

3256

2.54

93.55

1.7

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

105

110

9.84

90.16

45.6

34.9

ug/l

7.0

7.5

1.31

101

(3010375) cycloSPORINE [Mass/volume] in Blood

101

109

9.54

84.82

30.0

25.4

ug/l

95.6

117.5

2.12

(40760892) CBC W Ordered Manual Differential panel - Blood

993

5988

1.97

61.85

6.7

4.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

545

2863

2.10

48.42

9.7

6.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1364

9784

1.70

44.04

5.2

3.5

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1887

14887

1.68

41.33

10.9

8.9

e9/l

4.0

4.1

0.98

1723

13041

(3001604) Monocytes [#/volume] in Blood

1681

12885

1.66

41.05

8.0

5.9

e9/l

0.5

0.6

8.92

1534

11205

(3006315) Basophils [#/volume] in Blood

1683

12922

1.66

40.68

8.0

5.9

e9/l

0.0

0.17

1536

11240

(3019198) Lymphocytes [#/volume] in Blood

1718

13296

1.65

39.93

8.0

5.9

e9/l

1.9

0.08

1591

11805

(3013115) Eosinophils [#/volume] in Blood

1718

13379

1.63

38.24

8.1

6.1

e9/l

0.2

3.20

1591

11829

(3029937) Albumin [Presence] in Urine by Test strip

994

6774

1.69

37.31

5.8

3.7

estimate

0.0

0.06

320

2368

(3019150) Specific gravity of Urine by Refractometry

838

5470

1.73

36.80

5.4

3.7

kg/l

1.0

1.32

787

(40761535) Cells panel - Urine sediment

382

1950

2.09

35.94

5.6

3.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

241

1030

2.45

34.72

1.6

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1389

10498

1.58

33.25

2.7

2.2

nmol/l

77.8

75.9

2.02

1296

9570

(3009261) Glucose [Presence] in Urine by Test strip

1616

12727

1.56

31.75

5.1

3.4

estimate

0.0

1.32

318

2365

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2271

19351

1.64

31.75

10.3

7.3

u/l

73.9

76.7

2.20

2166

18286

(3021601) Nitrite [Presence] in Urine by Test strip

1603

12602

1.56

31.75

6.4

4.6

estimate

0.0

0.50

326

2446

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

150

529

2.93

31.59

11.7

5.9

iu/ml

2772.7

556.9

0.76

(3035350) Ketones [Presence] in Urine by Test strip

1597

12585

1.55

30.99

5.0

3.4

estimate

0.0

0.50

312

2388

(3015736) pH of Urine

1278

9729

1.53

28.10

4.7

3.2

—

5.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1345

10352

1.53

28.10

6.8

4.8

g/l

36.4

35.9

3.18

1273

9655

(3003458) Phosphate [Moles/volume] in Serum or Plasma

507

3082

1.77

27.71

12.0

6.0

mmol/l

1.1

1.0

3.84

489

2875

(4035726)

379

2121

1.90

27.07

1.6

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

372

2071

1.90

26.99

17.6

7.7

mmol/l

10.9

9.3

4.12

367

1981

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1496

11886

1.50

26.19

10.6

6.7

mmol/l

1.2

0.44

1263

10084

(3019550) Sodium [Moles/volume] in Serum or Plasma

2851

26268

2.00

25.88

19.2

14.6

mmol/l

139.8

139.6

2.33

2798

25621

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

408

2.97

25.76

4.2

2.9

u/ml

148.7

1633.3

—

(40768446) Kidney Pathology biopsy report

5.45

25.24

2.1

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1588

12838

1.48

25.08

7.6

6.1

umol/l

10.7

11.1

0.85

1522

12174

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

318

1737

1.93

24.34

6.8

3.9

ng/l

124.4

85.1

4.90

286

1536

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

434

2613

1.77

24.30

6.3

4.3

u/l

231.2

243.3

0.72

424

2481

(3023103) Potassium [Moles/volume] in Serum or Plasma

2850

26358

1.95

24.02

19.4

14.7

mmol/l

4.0

0.05

2792

25670

(3030981) Hyaline casts [#/volume] in Urine by Automated count

239

1190

2.09

23.74

4.4

2.8

e6/l

0.2

0.3

0.23

233

1152

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2820

26066

1.86

22.72

17.2

13.1

mg/l

19.9

22.6

4.53

2261

20472

(3005322) IgE [Units/volume] in Serum or Plasma

321

1798

1.88

22.71

1.2

1.3

u/ml

124.4

206.9

1.75

301

1664

(3021589) Normoblasts [#/volume] in Blood

1426

11448

1.45

22.37

12.3

9.1

e9/l

0.0

1.31

1227

9364

(3042733) HLA Ab [Presence] in Serum

5.36

22.30

6.2

4.9

—

(40768443) Skin Pathology biopsy report

212

1039

2.12

21.93

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

2468

22093

1.56

21.86

19.9

15.7

13.6

0.42

2437

21627

(3036481) Cortisol [Moles/volume] in Serum or Plasma

404

2460

1.74

21.60

3.3

2.1

nmol/l

365.0

372.4

0.35

381

2264

(40761511) CBC panel - Blood by Automated count

2918

27351

2.05

21.44

16.8

12.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

148

637

2.39

20.94

6.8

3.9

mg/l

1.7

1.5

2.06

140

589

(3017181) Myelocytes/100 leukocytes in Blood

355

2118

1.76

20.33

5.5

4.2

1.0

0.9

0.31

576

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2929

27567

2.04

20.07

20.6

14.8

umol/l

81.7

75.0

12.24

2929

27557

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.63

19.95

5.7

5.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2940

27720

2.07

19.84

13.2

9.8

u/l

25.7

26.3

0.97

2872

26834

(3025159) Blasts/100 leukocytes in Blood

325

1907

1.79

19.69

5.7

4.3

0.1

0.4

0.86

456

(3021440) Promyelocytes/100 leukocytes in Blood

338

2017

1.76

19.31

5.6

4.2

0.1

0.02

532

(3013707) Erythrocyte sedimentation rate by Westergren method

2159

18986

1.45

19.15

5.1

3.9

mm/h

11.0

11.2

0.33

2027

17673

(3000850) Epithelial cells [#/volume] in Urine

710

5099

1.51

18.98

3.9

2.5

e6/l

4.5

6.4

3.90

648

4476

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

116

470

2.52

18.72

1.5

1.4

u/l

26.2

25.9

0.04

390

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2287

20366

1.46

18.69

4.8

4.0

pmol/l

14.8

14.6

4.44

2135

18745

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1014

7828

1.44

18.66

3.8

2.6

u/l

58.2

57.1

0.36

951

7252

(3007853) Bacteria identified in Skin by Aerobe culture

454

2972

1.62

18.24

2.0

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

431

2.56

18.00

6.1

3.0

—

(3044889) 12 lead EKG panel

2004

17491

1.41

17.75

4.3

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1468

12179

1.39

17.50

4.2

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1128

8976

1.40

17.14

3.9

3.4

ng/l

45.3

50.8

0.23

751

5629

(3011397) Hemoglobin [Presence] in Urine by Test strip

779

5807

1.46

17.00

5.2

3.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2611

24029

1.53

16.78

5.6

4.7

mu/l

1.9

2.0

0.87

2472

22296

(3018418) pH of Serum or Plasma

912

7018

1.42

16.69

7.5

3.9

7.4

1.37

194

1345

(3002179) Metamyelocytes/100 leukocytes in Blood

317

1946

1.70

16.28

5.0

4.0

0.6

0.04

429

(3007461) Platelets [#/volume] in Blood

3037

29202

2.56

16.27

25.7

19.1

e9/l

251.6

254.6

1.73

3001

28530

(3035941) MCH [Entitic mass]

3038

29219

2.57

16.21

25.6

19.0

30.2

0.00

3017

28856

(3024731) MCV [Entitic volume]

3038

29219

2.57

16.21

25.6

19.1

90.7

0.06

3017

28859

(3026361) Erythrocytes [#/volume] in Blood

3038

29225

2.56

16.09

25.7

19.1

e12/l

4.5

0.03

2991

28485

(3010813) Leukocytes [#/volume] in Blood

3038

29229

2.55

16.01

25.8

19.2

e9/l

6.6

6.7

1.53

2989

28484

(3000963) Hemoglobin [Mass/volume] in Blood

3038

29234

2.55

15.91

25.8

19.2

g/l

135.8

135.7

0.17

3018

28868

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

924

7175

1.41

15.91

2.4

2.1

u/l

145.6

208.8

2.93

878

6784

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

320

1986

1.68

15.76

3.2

2.6

ml/min/173m2

55.7

70.0

7.36

159

754

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1305

10744

1.37

15.73

9.3

6.0

mmol/l

1.2

0.93

1207

9772

(3026493) Urate [Moles/volume] in Serum or Plasma

847

6502

1.42

15.50

3.6

2.6

umol/l

4358.6

4334.3

0.01

760

5691

(3012095) Magnesium [Moles/volume] in Serum or Plasma

548

3889

1.50

15.14

5.4

3.5

mmol/l

0.8

0.77

522

3661

(3013826) Glucose [Moles/volume] in Serum or Plasma

1687

14525

1.35

14.91

5.9

4.8

mmol/l

6.5

6.6

0.99

1582

13484

(3031040) Bacteria [#/volume] in Urine by Automated count

1904

16758

1.35

14.23

5.0

4.2

e6/l

292.9

1413.0

1.90

221

(3026782) Osmolality of Urine

640

4737

1.44

14.15

4.6

2.7

mosm/kgh2o

527.6

550.8

1.92

578

4045

(3035637) Corticotropin [Mass/volume] in Plasma

313

2.60

13.95

1.6

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

859

6716

1.39

13.84

4.3

3.0

e6/l

0.3

0.4

2.13

715

5046

(1761482) Bacteria [#/volume] in Urine by Culture

117

552

2.16

13.40

4.2

—

(3025941) Bacteria identified in Stool by Culture

253

1544

1.70

13.24

1.4

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

277

1744

1.65

12.87

5.6

3.2

kpa

4.9

4.6

1.08

270

1682

(3020891) Body temperature

166

902

1.89

12.86

6.5

4.8

—

(3048689) Calprotectin [Mass/mass] in Stool

470

3345

1.48

12.63

2.8

2.4

ug/g

127.0

123.4

0.07

393

2657

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2650

24787

1.46

12.52

5.1

4.2

mmol/l

5.8

5.9

1.58

2474

22844

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

182

1033

1.81

12.28

4.6

2.8

0.7

0.02

176

995

(3041096) Erythrocytes [Presence] in Urine by Automated

881

7034

1.35

12.14

4.2

3.1

—

(3026008) Bacteria identified in Urine by Culture

894

7156

1.35

12.11

3.3

2.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2715

25565

1.48

11.89

4.9

4.1

mmol/l

4.6

4.7

3.45

2579

23969

(3014576) Chloride [Moles/volume] in Serum or Plasma

416

2927

1.49

11.80

7.6

7.3

mmol/l

104.4

0.04

410

2857

(3037467) Urinalysis macro (dipstick) panel - Urine

1972

17671

1.32

11.76

5.2

4.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2744

25946

1.48

11.22

5.3

4.5

mmol/l

2.7

2.8

3.57

2576

24170

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

778

6165

1.35

11.10

3.7

3.0

ng/l

1457.0

1237.4

0.64

679

5214

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

121

622

1.98

11.08

1.5

1.3

—

(36304419) Bacteria [Presence] in Urine

828

6629

1.34

11.02

4.0

3.0

—

(3018095) Leukocytes [#/volume] in Urine

1056

8757

1.31

10.96

5.2

3.6

e6/l

90.5

96.9

0.07

848

6086

(3022948) Iron [Moles/volume] in Serum or Plasma

509

3771

1.42

10.94

4.3

2.4

umol/l

13.8

13.5

0.48

486

3496

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2612

24500

1.41

10.91

4.5

3.7

mmol/l

1.3

0.96

2445

22739

(3021447) Carbon dioxide [Partial pressure] in Venous blood

317

2141

1.54

10.91

6.3

3.9

kpa

5.8

5.9

0.16

310

2074

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

105

517

2.07

10.83

3.9

3.8

56.4

57.4

0.41

105

517

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1388

11971

1.29

10.58

3.7

2.8

ug/l

116.6

111.6

0.34

1317

11181

(3004789) Transferrin [Mass/volume] in Serum or Plasma

471

3464

1.42

10.52

4.4

2.4

g/l

2.3

2.4

0.44

455

3220

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

442

3215

1.44

10.49

4.6

2.5

24.1

23.4

0.51

389

2758

(3002032) Base excess in Venous blood by calculation

313

2126

1.52

10.49

6.4

3.9

mmol/l

1.7

2.0

0.68

259

1709

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

289

1931

1.55

10.44

6.6

3.6

mmol/l

1.2

0.05

258

1682

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

315

2.35

10.42

1.2

—

(3000494) Fungus identified in Specimen by Culture

417

3005

1.45

10.40

1.8

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.76

10.30

3.4

2.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

104

521

2.03

10.26

2.1

1.4

u/ml

103.3

116.6

0.62

101

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

539

4077

1.39

10.22

3.2

2.7

e6/l

1.7

1.0

0.42

369

2289

(3002582) Erythrocytes [#/volume] in Urine

900

7357

1.31

10.21

4.9

3.1

e6/l

35.0

86.5

2.54

760

5630

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

338

2.28

10.13

2.4

—

(3004775) Volume in Urine collected for unspecified duration

178

2.78

9.96

3.7

2.3

773.9

633.3

1.30

120

(3012544) pH of Venous blood

320

2208

1.50

9.94

6.4

3.9

—

7.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

983

8158

1.30

9.91

4.1

3.3

mmol/l

2.3

2.4

0.32

891

7222

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2686

25424

1.41

9.69

4.9

4.1

mmol/l

1.5

0.69

2526

23699

(3022096) Basophils/100 leukocytes in Blood

1354

11733

1.27

9.62

8.2

6.0

0.7

0.06

1289

10991

(3019069) Monocytes/100 leukocytes in Blood

1399

12173

1.27

9.60

8.4

6.3

8.4

8.5

0.12

1338

11453

(3006504) Eosinophils/100 leukocytes in Blood

1390

12104

1.27

9.41

8.2

6.0

2.8

0.16

1324

11314

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

619

4845

1.35

9.39

1.6

1.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

1434

12568

1.26

9.08

8.2

6.0

28.7

28.4

0.30

1365

11780

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

342

2.19

9.04

1.9

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2476

23200

1.33

9.03

6.4

5.2

mmol/mol

39.1

39.2

0.10

2335

21687

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

254

1706

1.53

8.96

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

106

564

1.91

8.84

2.2

1.4

—

(3032080) INR in Blood by Coagulation assay

1112

9487

1.27

8.74

9.9

8.7

inr

1.2

1.14

359

2836

(3018010) Neutrophils/100 leukocytes in Blood

1409

12390

1.25

8.44

7.9

5.8

57.3

56.9

0.52

1346

11648

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

433

2.01

8.43

2.0

1.8

—

(42870588) Differential panel, method unspecified - Blood

1013

8581

1.27

8.37

7.4

5.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

338

2447

1.43

8.17

3.8

3.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

105

576

1.85

8.01

2.1

1.4

—

24.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

210

1389

1.55

7.96

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.15

7.95

1.1

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

167

1053

1.62

7.76

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1122

9682

1.25

7.75

1.8

1.9

pmol/l

98.7

96.1

0.96

590

5150

(3020682) Albumin/Creatinine [Ratio] in Urine

848

7086

1.27

7.73

5.3

4.0

mg/mmol

15.9

9.1

1.96

579

4531

(3013512) EKG study

814

6769

1.27

7.72

4.6

3.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

203

1346

1.54

7.62

2.9

2.2

u/l

5805.8

5905.1

0.02

538

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

551

1.84

7.54

4.1

2.4

ug/min

95.1

108.1

0.16

347

(1616796) Gas panel - Central venous blood

516

1.87

7.50

6.0

3.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

217

1466

1.52

7.47

7.2

7.4

mmol/l

24.4

24.5

0.14

205

1363

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

384

2.00

7.42

1.3

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

247

1717

1.48

7.40

3.9

3.4

pmol/l

4.5

0.06

229

1537

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

564

1.80

7.02

1.5

1.2

u/ml

280.0

255.0

0.36

341

(3015171) Extractable nuclear Ab [Units/volume] in Serum

161

1033

1.59

6.99

1.3

1.2

u/ml

0.2

0.9

1.62

(3017446) Testosterone [Moles/volume] in Serum or Plasma

255

1807

1.45

6.93

2.0

2.2

nmol/l

12.9

12.6

0.30

236

1610

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

159

1021

1.59

6.89

1.3

miu/ml

219.3

224.9

0.07

491

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

13.79

6.88

1.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

470

3698

1.32

6.72

2.4

2.2

29.3

29.7

0.80

453

3579

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2559

24337

1.29

6.66

15.5

11.8

ml/min/173m2

81.7

84.8

9.47

2177

19998

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

182

2.38

6.54

2.7

2.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

734

6133

1.26

6.53

1.3

u/ml

1.2

1.6

0.61

238

1626

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

102

594

1.74

6.45

1.4

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.84

6.45

17.8

7.8

mmol/l

4.9

6.1

0.78

(3022145) Colonoscopy Study observation

366

2797

1.35

6.38

1.4

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

185

2.34

6.32

2.3

1.8

—

(3012516) Albumin [Mass/volume] in Urine

799

6764

1.24

6.30

4.3

3.3

mg/l

569.6

364.5

0.48

538

4336

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

339

2566

1.36

6.29

1.8

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

102

600

1.72

6.24

1.9

1.7

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

836

7121

1.24

6.22

5.1

4.7

ug/l

2.3

2.7

0.82

757

6403

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

341

2590

1.36

6.19

1.9

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

104

2.81

6.15

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

253

1833

1.41

6.11

1.9

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.09

6.04

1.5

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

129

815

1.61

6.02

1.4

1.3

u/l

10.3

10.1

0.04

111

664

(3022689) Creatine [Moles/volume] in Urine

3.35

5.99

1.4

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

103

615

1.70

5.98

1.9

1.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

267

1962

1.39

5.94

3.4

2.8

g/l

10.1

10.6

1.09

257

1799

(3020630) Protein [Mass/volume] in Serum or Plasma

252

1838

1.40

5.86

3.2

2.7

g/l

65.8

66.7

1.14

236

1696

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.18

5.82

2.8

2.2

—

(40758558) Short blood count panel - Blood

756

6420

1.23

5.72

8.0

6.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

113

704

1.63

5.60

5.1

4.1

mmol/l

3.9

0.09

107

653

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

196

2.21

5.56

2.4

2.2

17.7

13.2

0.66

(3011412) CD3 cells [#/volume] in Blood

249

2.07

5.55

2.5

e9/l

1.1

1.2

0.65

150

(3009508) Creatinine [Moles/volume] in Urine

864

7466

1.22

5.49

4.1

3.2

mmol/l

7.2

7.8

3.61

770

6349

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

122

780

1.59

5.45

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

374

1.84

5.27

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

268

1.99

5.27

2.0

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

123

795

1.57

5.26

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

122

788

1.57

5.23

1.3

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

418

3346

1.29

5.22

2.1

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

108

2.61

5.22

6.3

3.6

—

(3024932) HLA-DR beta [Type]

2.76

5.20

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

103

2.64

5.14

1.3

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

217

2.09

5.09

4.1

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

258

1.99

5.08

3.6

2.6

—

(40767503) Oxygen content in Capillary blood by calculation

476

1.72

5.04

3.8

2.6

16.3

16.4

0.07

242

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

403

1.78

4.99

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

116

752

1.56

4.92

3.3

3.5

u/ml

0.3

2.16

423

(3019060) Gas panel - Arterial blood

209

1524

1.40

4.90

4.6

5.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

290

2231

1.33

4.85

6.6

8.9

g/l

120.4

122.2

0.76

278

2144

(44806118)

298

1.90

4.83

2.0

1.6

—

(44790049)

298

1.90

4.83

2.0

1.6

—

(44790048)

298

1.90

4.83

2.0

1.6

—

(44790047)

298

1.90

4.83

2.0

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

975

8611

1.19

4.79

3.7

3.2

u/l

28.3

32.3

4.25

928

8199

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

118

774

1.55

4.76

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

650

5528

1.22

4.76

1.5

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1952

18282

1.18

4.73

3.3

3.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.80

4.71

3.2

2.3

—

(3023520) Reticulocytes [#/volume] in Blood

248

1874

1.35

4.68

2.4

2.8

e9/l

70.8

71.0

0.04

200

1409

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

134

908

1.50

4.66

2.2

2.0

ug/l

2.1

1.8

0.15

129

806

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

551

4618

1.23

4.63

1.3

iu/ml

20.5

31.0

2.28

172

1434

(3023368) Bacteria identified in Blood by Culture

730

6298

1.21

4.60

4.9

4.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

252

1914

1.34

4.60

2.5

2.3

ug/l

8.0

7.2

0.17

231

1716

(3016502) Oxygen saturation in Arterial blood

306

2392

1.31

4.58

6.4

8.6

96.2

95.8

0.61

295

2304

(3000034) Microalbumin [Mass/volume] in Urine

206

2.05

4.58

3.0

3.2

mg/l

68.1

42.3

0.21

152

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

731

6311

1.21

4.57

2.5

2.1

mg/l

2.8

2.9

0.30

666

5390

(3024471) HLA-A [Type]

2.62

4.56

1.0

—

(3021901) Oxygen saturation in Capillary blood

408

1.73

4.52

4.1

2.9

—

(3000330) Specific gravity of Urine by Test strip

167

1190

1.43

4.49

4.9

3.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

139

957

1.47

4.48

1.5

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

293

1.86

4.42

1.6

1.4

pmol/l

243.2

293.6

0.87

229

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

118

791

1.51

4.34

3.3

2.7

g/l

3.4

3.6

0.57

111

742

(3003338) MCHC [Mass/volume]

2382

22760

1.20

4.33

21.4

16.5

g/l

332.9

332.6

0.79

2372

22603

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

288

1.85

4.33

1.8

1.7

—

(3012501) Base excess in Blood by calculation

530

1.62

4.28

6.1

4.4

mmol/l

2.4

0.00

356

(40768793) Breast Pathology biopsy report

577

1.59

4.28

1.3

—

(3042936) Bacteria identified in Isolate by Culture

431

3548

1.25

4.26

2.4

2.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

226

1.96

4.25

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

226

1.96

4.25

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

226

1.96

4.25

1.9

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

170

1228

1.41

4.25

2.1

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

144

1010

1.45

4.23

2.3

1.8

g/l

1.4

1.5

1.55

136

877

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

1.77

4.21

2.1

1.6

—

(3000991) Gas panel - Venous blood

252

1950

1.32

4.08

9.2

9.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

187

1385

1.37

4.04

1.9

3.1

u/ml

53.3

45.1

0.18

179

1335

(3007930) Methemoglobin/Hemoglobin.total in Blood

136

955

1.44

3.99

4.2

6.1

0.9

0.32

130

889

(3022217) INR in Platelet poor plasma by Coagulation assay

348

2821

1.26

3.93

22.6

22.7

inr

1.2

1.3

1.15

422

(3028026) IgM [Mass/volume] in Serum or Plasma

204

1541

1.35

3.90

2.2

1.8

g/l

1.2

1.4

0.55

192

1421

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

556

4748

1.21

3.86

2.0

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.48

3.79

1.0

1.1

85.3

91.4

0.40

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

109

745

1.48

3.70

3.2

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

472

1.60

3.69

1.8

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

517

4403

1.21

3.68

1.3

u/ml

15.5

11.5

0.15

231

1774

(3019309) Folate [Moles/volume] in Red Blood Cells

487

4124

1.21

3.68

1.7

nmol/l

1321.9

1177.5

3.09

400

3153

(3010421) pH of Blood

632

1.52

3.67

5.7

4.3

7.4

0.89

522

(46235355) HIV 1 and 2 tests - Meaningful Use set

662

5771

1.19

3.65

2.1

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

109

749

1.47

3.61

1.8

1.7

—

(4062490)

262

1.81

3.60

1.9

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

134

959

1.42

3.58

4.3

6.0

1.4

1.7

3.71

128

891

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

328

2672

1.25

3.57

6.2

8.1

kpa

5.1

0.33

311

2549

(3027801) Oxygen [Partial pressure] in Arterial blood

328

2673

1.25

3.56

6.2

8.1

kpa

12.4

12.6

0.23

312

2551

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.45

3.54

2.6

1.6

—

(3003396) Base excess in Arterial blood by calculation

328

2675

1.25

3.53

6.2

8.1

mmol/l

1.0

1.1

0.11

246

2077

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

192

1.94

3.53

1.3

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

264

1.79

3.52

1.9

1.8

—

(4010399)

224

1743

1.31

3.51

1.6

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

654

5714

1.18

3.50

4.8

4.1

22.8

21.4

1.67

354

2677

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

111

771

1.46

3.49

3.6

2.6

168.7

184.1

1.09

103

739

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.42

3.47

1.0

1.3

89.6

91.4

0.06

(3047352) Trisomy 18 risk [Likelihood] in Fetus

738

0.56

3.46

1.2

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

394

1.64

3.46

1.4

—

(3005033) Fetal Nuchal fold Thickness US

734

0.57

3.40

1.2

1.4

—

(3004451) EKG impression Narrative

107

2.25

3.38

1.1

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

756

0.58

3.35

1.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

287

2320

1.26

3.35

2.0

1.9

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

118

839

1.42

3.30

1.7

1.6

iu/ml

21.6

0.2

0.67

161

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

190

1.91

3.29

2.7

2.6

e6/l

705.5

701.4

0.01

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

450

3826

1.21

3.26

3.8

2.8

e6/l

2.7

2.5

0.14

280

2043

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

286

1.72

3.25

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

441

1.58

3.23

2.0

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

446

3795

1.20

3.20

2.0

1.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

2.09

3.18

1.3

1.1

miu/ml

1815.4

1590.6

0.50

130

(3047007) Chlamydophila sp Ab [Presence] in Serum

404

1.60

3.16

1.3

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

190

1472

1.31

3.11

8.1

10.0

94.1

94.0

0.06

190

1465

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

191

1484

1.31

3.06

7.9

9.9

0.7

1.73

191

1474

(3009445) Proteinase 3 Ab [Units/volume] in Serum

138

1022

1.37

3.06

1.7

1.5

u/ml

11.9

18.5

—

(3037522) Nuclear Ab [Titer] in Serum

429

3655

1.20

3.04

1.5

1.3

titre

514.9

527.7

0.05

749

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

116

838

1.40

2.99

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

950

0.65

2.98

1.8

2.0

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

190

1482

1.30

2.97

7.9

9.8

1.4

0.22

190

1473

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.64

2.96

1.5

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

609

5362

1.17

2.94

1.9

1.4

g/l

2.2

2.3

0.82

427

3371

(3009871) Measles virus Ab [Titer] in Serum

2.28

2.93

1.9

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

350

1.61

2.91

1.3

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

105

750

1.41

2.90

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.38

2.89

1.2

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.38

2.89

2.1

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.70

2.88

1.0

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

259

1.71

2.87

1.7

1.4

g/l

2.8

2.9

0.15

179

(3024139) IgG subclass 3 [Mass/volume] in Serum

259

1.71

2.87

1.7

1.4

g/l

0.3

0.4

1.07

178

(3027135) IgG subclass 1 [Mass/volume] in Serum

260

1.70

2.83

1.7

1.4

g/l

5.9

6.7

1.02

180

(21494755) Public health laboratory ask at order entry panel

244

2989

0.80

2.83

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

223

1.76

2.81

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

129

1713

0.74

2.81

1.9

1.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.06

2.80

1.3

2.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

588

1.46

2.80

4.7

3.2

mmol/l

24.5

24.8

0.24

517

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.45

2.79

1.8

2.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

516

1.48

2.75

3.3

2.3

g/l

127.3

130.9

0.74

373

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.01

2.72

8.6

5.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

118

2.04

2.71

1.4

1.2

—

(4027681)

175

1.84

2.68

1.3

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

1.96

2.65

1.5

1.6

nmol/l

1.5

7.7

1.06

110

(3000570) Elastase.pancreatic [Mass/mass] in Stool

705

1.40

2.63

1.4

ug/g

292.1

289.5

0.04

396

(3027944) Amphetamines [Presence] in Urine

1189

0.71

2.58

1.9

2.0

—

(3016879) Cocaine [Presence] in Urine

1116

0.70

2.55

1.9

2.1

—

(1761868) Lipid panel - Serum or Plasma

1060

9785

1.13

2.53

3.2

2.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

635

1.41

2.52

1.4

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

122

1.97

2.50

1.3

1.1

—

4.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

120

901

1.35

2.50

1.8

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1215

0.72

2.49

1.8

2.0

—

(3011648) Oxygen content in Venous blood

195

1.75

2.46

2.7

3.0

11.2

11.3

0.04

195

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

291

3449

0.83

2.46

1.8

1.4

0.56

259

3058

(3027008) Opiates [Presence] in Urine

1210

0.72

2.43

1.8

2.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.29

2.41

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

192

1545

1.26

2.40

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

235

1.67

2.38

1.3

1.2

u/l

65.3

57.4

0.29

167

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.12

2.38

1.2

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

484

4257

1.16

2.37

2.9

mmol/l

2.4

1.55

428

3738

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

110

823

1.35

2.36

2.5

2.4

ug/l

514.6

478.0

0.06

101

766

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.12

2.36

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

302

2554

1.20

2.35

3.2

2.8

1.8

0.10

285

2276

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

649

5834

1.14

2.34

2.1

1.8

mg/l

1.0

1.1

0.42

507

4395

(3000764) Benzodiazepines [Presence] in Urine

1201

0.72

2.34

1.8

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

535

0.59

2.30

2.5

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

111

836

1.34

2.29

3.3

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

178

1.75

2.26

1.1

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

423

1.48

2.25

2.2

umol/l

5.0

5.7

0.26

307

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

216

1.67

2.25

1.1

mg/l

220.6

252.8

0.69

188

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

186

1.73

2.24

1.2

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

142

1112

1.29

2.23

1.1

u/ml

2.4

0.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

164

1.78

2.23

3.6

2.8

44.0

41.1

—

(3003694) ABO and Rh group [Type] in Blood

840

7698

1.12

2.23

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.11

2.22

1.9

1.3

ng/l

138.4

116.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

272

2293

1.20

2.21

3.6

4.1

ug/l

5.1

22.2

3.04

206

1831

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

113

860

1.33

2.19

2.9

2.4

93.4

91.9

0.29

101

804

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

104

782

1.34

2.18

1.1

u/ml

15.2

4.1

0.66

111

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

220

1819

1.23

2.17

2.4

au/ml

16.8

21.0

0.33

114

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

188

1.71

2.17

1.6

1.2

—

(40768795) Lymph node Pathology biopsy report

234

1.63

2.17

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

352

3042

1.18

2.16

1.5

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

698

1.36

2.14

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

975

0.71

2.13

1.3

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

184

1497

1.24

2.12

2.3

2.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

190

1.69

2.10

1.7

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

566

5084

1.14

2.06

1.6

pmol/l

12134325.4

35068090.1

0.92

478

4286

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

317

1.52

2.06

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

189

1549

1.23

2.05

1.3

iu/l

26.2

28.1

0.36

169

1316

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

147

1.78

2.02

1.6

1.4

u/l

12.4

13.7

0.39

140

(40761536) Microorganisms panel - Urine sediment

264

2244

1.19

1.98

6.6

3.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

269

2292

1.19

1.97

2.5

2.2

g/l

0.2

1.10

257

2150

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.55

1.94

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.55

1.94

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

413

1.44

1.92

1.3

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

203

1.63

1.92

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

137

1096

1.26

1.86

2.1

1.9

u/l

39.3

39.2

0.02

128

986

(3025018) Bordetella pertussis Ab [Titer] in Serum

159

1.70

1.85

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

261

1.54

1.84

5.4

4.8

u/ml

263.6

81.1

0.36

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

250

0.48

1.84

1.8

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.53

1.83

1.0

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.06

1.80

3.9

2.3

e6/l

163.0

145.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

370

3260

1.15

1.80

1.9

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

899

0.73

1.80

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

898

0.73

1.79

1.2

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

240

2044

1.19

1.79

7.3

7.7

mmol/l

1.3

1.4

0.57

225

1965

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

169

1.66

1.77

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

461

0.63

1.76

1.4

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

216

1.58

1.76

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

895

0.73

1.76

1.2

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

216

1826

1.20

1.75

3.1

2.9

ng/l

171.0

185.0

0.22

204

1653

(3036489) Thrombin time

126

1007

1.26

1.74

2.7

2.2

21.6

21.2

0.27

113

874

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.23

1.73

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.85

1.71

1.2

1.3

—

(4306422)

432

1.40

1.71

1.2

—

(40757373) Influenza virus identified in Isolate

2.30

1.70

2.3

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

382

1.42

1.70

1.3

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

197

1657

1.20

1.69

1.3

au/ml

72.4

50.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

370

0.59

1.69

1.4

1.2

—

(3003181) Sodium [Moles/volume] in Urine

391

1.41

1.68

1.4

mmol/l

54.4

63.8

1.36

324

(3050129) First trimester maternal screen panel - Serum or Plasma

139

1129

1.24

1.68

1.6

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

235

1.54

1.67

2.0

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

163

0.43

1.66

2.7

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.89

1.65

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

896

0.74

1.64

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

107

846

1.27

1.63

2.7

2.6

—

(3037756) Immunofixation for Serum or Plasma

462

1.37

1.62

1.4

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

584

1.33

1.60

1.3

1.5

e6/l

1818.0

1174.4

0.14

477

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

584

1.33

1.60

1.2

1.4

e6/l

20.4

30.3

0.20

452

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

524

1.34

1.59

1.3

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.00

1.58

1.3

1.1

—

(3000012) Reticulocyte production index

114

1.76

1.56

1.2

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

305

1.45

1.56

1.2

1.3

nmol/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.85

1.56

1.4

1.2

—

(4146454)

246

0.53

1.53

2.9

2.7

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

100

1.80

1.53

2.4

2.3

ug/l

1.3

1.1

0.24

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

130

1.70

1.53

1.4

1.3

—

816.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

511

1.34

1.52

1.3

1.5

nmol/l

0.5

0.4

0.29

405

(3008898) HLA-B27 [Presence]

128

1045

1.23

1.51

1.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.16

1.50

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

162

1.61

1.49

8.1

6.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

234

1.50

1.49

1.2

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

436

1.36

1.48

1.4

1.3

ug/l

2.5

3.9

1.35

398

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

404

0.64

1.47

1.2

—

(3045424) Erythrocytes [Presence] in Urine

428

1.36

1.46

2.2

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

506

1.33

1.46

3.0

3.7

—

(3008295) Osmolality of Serum or Plasma

260

1.47

1.45

1.7

1.5

mosm/kgh2o

280.8

280.3

0.06

204

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.13

1.44

1.0

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.13

1.44

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.04

1.43

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.04

1.43

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.04

1.43

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.04

1.43

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

501

1.32

1.40

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

189

1.54

1.40

1.1

1.3

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.42

1.39

1.4

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

166

1405

1.19

1.38

5.4

3.6

mmol/l

1.5

1.7

0.29

118

1043

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

349

3125

1.13

1.38

1.7

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

0.41

1.36

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

120

1.67

1.34

1.6

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

393

1.35

1.32

1.7

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

714

6659

1.09

1.32

1.7

1.6

mmol/l

1.3

1.4

0.55

605

5644

(3045414) Leukocytes [Presence] in Urine

138

1156

1.20

1.30

2.3

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

2495

24478

1.10

1.29

15.6

13.9

39.6

40.0

1.15

1741

18504

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

145

1.59

1.29

1.4

1.6

u/l

14.6

6.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

261

2943

0.88

1.26

4.8

4.2

33.9

32.2

1.70

186

2063

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

170

1.53

1.25

1.0

1.1

iu/ml

8.9

10.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

107

1.69

1.25

1.9

—

(3024928) Oxygen saturation in Venous blood

502

1.30

1.25

4.4

3.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.40

1.24

1.0

—

(3011288) Drugs identified in Urine by Screen method

844

0.78

1.24

2.2

2.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

123

1.63

1.24

1.6

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

679

6338

1.09

1.23

4.7

3.9

92.4

91.9

0.21

661

6171

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.91

1.22

1.2

—

(40768797) Stomach Pathology biopsy report

387

3515

1.12

1.22

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

247

2183

1.14

1.21

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.17

1.21

1.1

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.80

1.21

1.5

1.2

—

(3024263) Appearance of Synovial fluid

124

1.62

1.20

2.1

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

297

1.39

1.20

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

853

8050

1.08

1.19

2.6

2.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

222

1.45

1.18

1.4

nmol/l

1.6

1.5

0.20

196

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

109

1.66

1.18

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

133

1123

1.19

1.17

6.7

4.2

mmol/l

23.7

24.1

0.88

120

1019

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

199

1.46

1.14

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

127

1.58

1.11

1.4

1.3

—

68.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

818

1.22

1.11

1.8

1.6

titre

576.0

285.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

415

1.31

1.10

1.6

g/l

0.5

0.8

1.03

316

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

939

0.80

1.09

1.7

1.8

—

(3025577) Chromium [Mass/volume] in Blood

136

0.51

1.09

2.6

2.1

ug/l

3.0

2.2

—

116

(3021960) Folate [Moles/volume] in Serum or Plasma

580

5407

1.09

1.6

1.5

nmol/l

20.7

20.5

0.10

517

4690

(3014051) Protein [Presence] in Urine by Test strip

592

0.76

1.07

2.8

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

586

1.25

1.07

1.1

u/ml

1.2

1.3

0.08

228

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

341

1.32

1.03

1.7

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

169

1476

1.15

1.02

5.5

3.6

kpa

5.1

5.2

0.33

164

1376

(44816559) Phosphatidylethanol [Mass/volume] in Blood

530

0.75

1.02

1.4

1.3

—

(3009343) pH of Capillary blood

167

1458

1.15

1.01

5.5

3.6

7.4

0.25

185

(3040151) Glucose [Moles/volume] in Capillary blood

256

1.37

1.00

4.8

6.1

mmol/l

7.8

7.3

0.33

216

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

375

3444

1.10

0.99

1.9

2.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

0.98

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

301

1.33

0.97

1.2

1.1

—

(4094501)

667

1.22

0.97

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.80

0.96

1.2

1.4

—

(4281824)

259

0.65

0.96

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

174

1.44

0.95

1.4

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.77

0.94

1.1

73.0

97.9

—

(4034850)

822

0.81

0.94

12.2

9.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

101

1.59

0.93

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

176

1.42

0.90

1.4

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

151

1.46

0.90

1.3

1.4

mmol/l

5.5

5.8

0.57

146

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1002

0.83

0.90

2.0

—

(3036603) Volume of Urine

168

1.43

0.89

1.6

1.4

2240.7

2102.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

219

1.37

0.89

1.7

1.5

35.1

32.6

0.13

137

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.86

0.87

1.0

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.86

0.87

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.86

0.87

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.86

0.87

1.0

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

224

2021

1.12

0.85

1.3

1.2

iu/ml

96.7

151.4

2.08

765

(3010144) Erythrocytes [#/volume] in Synovial fluid

247

1.34

0.85

1.2

1.3

e6/l

169291.2

91572.6

0.19

167

(1002224) Polysomnography panel

1157

0.85

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.57

0.84

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.57

0.84

1.7

1.4

—

(3019977) pH of Arterial blood

129

1.48

0.83

1.7

3.2

7.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

139

0.57

0.83

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.69

0.82

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

131

1146

1.15

0.82

1.5

1.7

mg/l

2.4

4.0

1.44

794

(3045683) HLA typing for celiac disease panel - Blood or Tissue

180

1.39

0.82

1.0

—

(36660697) Celiac disease serology panel - Serum

241

2190

1.11

0.81

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

232

1.34

0.81

3.9

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

155

1.42

0.81

1.8

1.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

673

1.19

0.80

3.2

3.6

mg/l

38.8

77.5

1.01

548

(3034860) Kappa light chains.free [Mass/volume] in Serum

673

1.19

0.80

3.2

3.6

mg/l

61.3

64.9

0.09

547

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

130

1.46

0.80

2.2

2.7

u/ml

487.8

1169.3

2.33

130

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.82

0.79

3.2

10.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.82

0.79

1.0

1.2

—

640.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

657

1.19

0.78

1.6

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

194

1748

1.12

0.77

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

385

1.25

0.77

1.9

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.70

0.75

1.4

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

723

0.83

0.75

1.1

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

525

1.20

0.72

1.9

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

903

0.85

0.72

1.8

—

(3035880) pH of Pleural fluid

117

1.46

0.71

1.5

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.58

0.71

5.2

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

410

3846

1.08

0.70

2.0

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

212

1.32

0.70

1.2

1.1

—

(3039000) Anion gap in Blood

546

1.19

0.69

4.9

8.4

mmol/l

11.6

11.4

0.17

485

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

119

1345

0.88

0.68

1.6

—

(3018572) Chloride [Moles/volume] in Blood

547

1.19

0.68

4.9

8.4

mmol/l

105.7

105.5

0.21

486

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.67

0.68

1.3

1.1

—

7.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

136

1.40

0.66

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

1.40

0.66

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

136

1.40

0.66

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

136

1.40

0.66

1.7

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.79

0.66

1.0

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.79

0.66

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

179

0.67

0.66

1.4

1.3

—

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

167

0.66

2.5

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.65

1.8

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

111

1.44

0.65

1.8

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

112

1.43

0.63

1.8

2.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

387

1.22

0.63

1.3

mmol/l

7.0

7.2

0.23

281

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

451

1.20

0.63

1.3

1.2

u/ml

1.5

4.5

2.28

156

(3047181) Lactate [Moles/volume] in Blood

776

1.15

0.62

4.3

7.1

mmol/l

1.3

0.11

669

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

890

0.86

0.62

1.6

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

199

1.31

0.62

2.0

2.1

—

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

415

1.21

0.62

1.1

—

(4268621)

297

1.25

0.62

2.2

2.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

182

1.32

0.61

1.1

ratio

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

187

0.69

0.61

1.5

—

67.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

139

0.65

0.60

1.6

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

165

1.34

0.60

1.2

1.1

nmol/l

—

4.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

209

1.29

0.60

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

26.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

272

1.25

0.59

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.54

0.59

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

381

1.21

0.59

1.2

u/l

25.9

35.6

0.32

327

(3014133) Dog dander IgE Ab [Units/volume] in Serum

437

1.19

0.58

1.0

1.1

u/ml

3.5

3.7

0.03

155

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.46

0.58

1.0

—

(44813793)

193

1.30

0.57

1.2

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.67

0.56

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.56

1.2

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

479

4560

1.06

0.55

3.9

3.5

ng/l

617.7

457.8

0.30

340

3279

(3000475) Leukocytes [#/volume] in Synovial fluid

588

1.16

0.55

1.6

1.7

e6/l

27227.8

13250.4

0.29

431

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

524

1.17

0.54

8.8

2.2

nmol/l

0.9

0.8

0.43

438

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.47

0.54

1.0

1.1

u/ml

0.1

3.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

151

1.33

0.54

1.1

1.6

u/l

5.0

7.8

1.37

128

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

116

1043

1.12

0.53

1.7

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.48

0.53

1.4

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.49

0.53

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.49

0.53

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.54

0.53

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

226

0.75

0.52

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

169

0.71

0.52

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.41

0.51

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

287

1.22

0.51

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

135

1.34

0.51

1.9

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

135

1.34

0.51

1.9

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

206

1.26

0.51

2.1

1.4

g/l

0.9

1.0

0.68

206

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

250

2669

0.93

0.50

1.8

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

288

1.22

0.50

1.3

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

288

1.22

0.50

1.3

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

643

1.14

0.48

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.52

0.48

1.0

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1484

1.09

0.47

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

290

1.21

0.47

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

290

1.21

0.47

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

222

0.76

0.47

1.4

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

676

0.87

0.47

2.1

2.4

g/l

36.4

38.0

1.11

599

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

118

0.68

0.45

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.45

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

140

1287

1.09

0.45

6.7

11.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

293

1.20

0.44

1.3

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.25

0.43

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

193

1.25

0.43

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.25

0.43

1.3

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

461

1.15

0.43

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

511

0.86

0.43

2.4

3.0

umol/l

32.6

33.9

0.13

442

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

542

0.87

0.42

1.3

1.2

u/ml

2.6

3.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

194

1.24

0.42

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

194

1.24

0.42

1.3

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

616

0.87

0.42

2.2

2.4

g/l

0.0

0.00

576

(3023430) Cat dander IgE Ab [Units/volume] in Serum

397

1.16

0.42

1.0

1.1

u/ml

2.7

4.4

0.84

153

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

295

1.19

0.41

1.7

1.6

58.2

58.9

0.03

190

(3051101) Glucose [Moles/volume] in Cord blood

1.52

0.41

1.6

6.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.52

0.41

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

0.00

0.41

0.0

1.7

—

69.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.2

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

379

1.16

0.41

3.3

3.2

nmol/l

0.9

0.8

0.10

298

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.40

0.0

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

195

1.23

0.40

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.47

0.40

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

435

4176

1.05

0.40

3.0

ug/l

0.7

0.00

281

2698

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.3

—

(3015183) Erythrocyte sedimentation rate

171

0.76

0.39

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

3.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.39

0.0

1.4

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.3

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

612

0.88

0.39

2.2

2.4

g/l

0.0

0.00

575

(3016650) Hepatitis A virus Ab [Presence] in Serum

457

1.14

0.38

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.3

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

247

0.81

0.38

3.1

1.7

ug/l

37.1

24.1

0.32

242

(3006922) Hepatitis E virus Ab [Presence] in Serum

181

0.77

0.38

1.1

—

(3017732) Neutrophils [#/volume] in Blood

194

1825

1.07

0.37

1.8

2.8

e9/l

4.6

4.1

1.70

170

1481

(3010726) Horse dander IgE Ab [Units/volume] in Serum

496

1.13

0.37

1.0

1.1

u/ml

2.3

2.4

0.03

112

(3004616) Nuclear Ab [Presence] in Serum

322

0.84

0.37

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

114

0.70

0.37

1.0

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.36

0.36

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.27

0.36

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

212

0.80

0.35

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

701

0.90

0.35

1.3

1.2

u/ml

3.1

6.7

—

120

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.40

0.35

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.37

0.34

2.0

1.7

—

164.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.36

0.34

3.5

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

700

1.10

0.34

1.4

1.2

titre

69.1

94.5

0.73

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.34

0.34

1.2

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.34

0.34

1.9

3.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

462

1.13

0.34

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

114

1229

0.92

0.34

8.9

10.5

mmol/l

24.0

24.3

0.71

102

1163

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

740

0.90

0.33

2.5

g/l

1.1

0.02

659

(3037121) Protein [Mass/volume] in Urine

836

1.09

0.33

4.8

3.4

g/l

0.3

0.10

342

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

464

1.12

0.32

1.6

1.7

—

(3000492) Spirometry study

245

2569

0.95

0.32

1.5

1.4

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

300

2876

1.05

0.31

3.6

2.7

umol/l

6.2

7.8

1.42

269

2500

(3021387) Prolactin [Units/volume] in Serum or Plasma

124

1157

1.07

0.31

1.9

1.7

mu/l

293.7

296.0

0.04

118

1043

(3019225) pH of Specimen

223

2343

0.95

0.31

6.5

4.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

568

0.90

0.30

1.3

1.2

u/ml

57.1

44.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

438

1.12

0.30

1.4

1.2

u/ml

6.0

5.0

0.16

187

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.25

0.29

1.0

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

182

1727

1.06

0.29

1.5

—

(21494434) Karyotype in Bone marrow

206

0.82

0.29

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

167

1.20

0.28

1.2

1.1

u/l

1.0

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

690

0.91

0.28

1.4

1.2

u/ml

1.4

2.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

481

0.89

0.28

1.1

—

(3025130) Human papilloma virus identified in Specimen

417

0.89

0.27

2.2

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

196

1.17

0.27

3.4

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

122

1.23

0.27

1.2

1.1

iu/ml

294.4

204.5

0.21

122

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

104

1.25

0.26

1.2

116.0

107.3

0.92

(3023410) Appearance of Cerebral spinal fluid

257

0.86

0.26

1.3

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

478

0.90

0.26

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

655

0.91

0.26

2.1

2.4

g/l

0.0

0.14

614

(3023511) Choriogonadotropin [Units/volume] in Urine

717

0.92

0.25

1.6

1.3

—

(4133840)

0.67

0.25

1.2

—

(3021788) Differential panel - Synovial fluid

434

1.11

0.25

1.7

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

235

0.85

0.25

7.9

3.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

791

1.08

0.25

3.1

3.6

u/ml

314.8

5168.0

0.78

680

(3006653) Thiamine [Moles/volume] in Blood

142

1.20

0.24

1.4

1.3

nmol/l

146.8

133.8

0.95

142

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

264

1.14

0.24

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

170

1.18

0.24

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.27

0.24

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

417

1.10

0.24

1.2

1.0

u/ml

3.8

2.4

0.29

202

(3051387) C reactive protein [Mass/volume] in Capillary blood

537

0.91

0.23

3.2

3.5

mg/l

17.7

24.6

1.55

339

(3024869) Neuronal Ab [Presence] in Serum

1.32

0.23

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

453

0.90

0.23

2.1

1.7

—

(3047189) Immunofixation for 24 hour Urine

106

1.23

0.23

1.2

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.28

0.23

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.25

0.22

1.6

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.22

1.4

1.1

—

(3034426) Prothrombin time (PT)

0.75

0.22

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

314

1.12

0.22

2.0

2.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.1

—

4092.8

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3042631) Mycobacterium sp identified in Specimen

296

1.12

0.21

2.5

2.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

283

0.88

0.21

1.9

2.2

mg/l

23.1

23.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.5

—

9.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.22

0.20

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

250

1.12

0.19

1.4

mmol/l

9.3

12.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.15

0.19

2.2

1.3

ug/l

0.5

0.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

194

1.13

0.18

1.3

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.17

0.18

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

100

1.20

0.18

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

157

1.15

0.17

1.4

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

603

6133

0.98

0.17

2.5

2.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

591

1.07

0.17

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

131

0.84

0.17

1.1

—

(3020650) Glucose [Presence] in Urine

0.73

0.17

1.0

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

175

1811

0.96

0.16

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

120

1.17

0.16

1.1

3.1

umol/l

80.9

136.3

—

(3029075) Extractable nuclear Ab panel - Serum

1.10

0.15

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

264

1.10

0.15

5.7

3.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

216

1.11

0.15

1.7

1.2

u/ml

1.3

0.5

0.54

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.21

0.15

1.2

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

182

0.88

0.15

19.0

18.1

nmol/l

1623.5

1532.6

0.24

177

(4198724)

118

0.85

0.14

2.9

1.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

919

0.96

0.13

6.0

3.8

mmol/l

24.1

24.8

2.07

854

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

170

0.88

0.13

1.1

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

853

1.04

0.13

1.9

2.5

g/l

4.2

3.8

0.27

633

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

180

0.89

0.13

11.4

13.2

nmol/l

1016.3

854.4

0.64

174

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

1.04

0.12

2.0

2.4

g/l

7.5

7.3

0.38

664

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

854

1.04

0.12

1.9

2.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

531

1.06

0.12

1.1

u/ml

3.1

5.6

1.41

277

(3022313) Gas panel - Capillary blood

110

1063

1.04

0.12

5.9

3.7

—

(3017569) Oxygen content in Arterial blood

114

1.14

0.11

1.6

2.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

168

0.89

0.11

1.1

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

690

1.04

0.11

1.9

2.0

iu/l

2.9

4.8

3.66

253

(40768800) Prostate Pathology biopsy report

435

1.06

0.11

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

211

1.09

0.11

1.6

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.16

0.11

1.8

1.4

ug/l

8.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

187

0.91

0.10

1.4

2.0

u/field

1.9

—

(4024509)

222

1.08

0.10

1.6

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

193

1.09

0.10

1.6

2.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

135

0.89

0.09

1.6

2.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

8.8

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.06

0.09

1.4

2.0

mmol/l

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.04

0.09

2.4

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.04

0.09

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

724

1.04

0.09

3.9

3.2

—

(3022621) pH of Urine by Test strip

160

1635

0.98

0.09

2.5

2.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

247

0.93

0.08

1.4

1.6

mmol/l

6.9

7.7

1.36

150

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

235

2387

0.98

0.08

3.7

2.4

u/l

31.6

59.1

0.77

208

2040

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

166

1.08

0.07

1.3

1.5

—

(40765096) Chromosome analysis panel by Banding

0.80

0.07

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

398

0.95

0.07

1.3

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.03

0.07

1.6

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.03

0.07

1.6

2.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.03

0.07

1.2

1.7

—

(3044927) Protein electrophoresis panel - Urine

216

1.07

0.06

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

1.09

0.06

1.1

—

(3014271) Vancomycin [Susceptibility]

101

0.89

0.06

2.4

2.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

809

0.98

0.05

2.0

2.5

g/l

3.1

0.19

647

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

484

1.03

0.05

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

484

1.03

0.05

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

179

1.06

0.05

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1787

17830

1.01

0.04

3.4

3.0

u/l

43.3

45.2

0.49

1705

16812

(3045142) Bone marrow Pathology biopsy report

271

0.96

0.04

1.2

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

794

0.98

0.03

2.0

2.5

g/l

9.2

10.4

2.13

686

(3008401) Mugwort IgE Ab [Units/volume] in Serum

508

1.02

0.03

1.1

u/ml

0.6

1.3

0.71

210

(3028433) Virus identified in Specimen by Culture

1.09

0.03

1.4

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

102

1.08

0.03

1.0

1.1

—

4.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

1.08

0.03

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

219

0.96

0.03

4.5

4.0

—

(40768441) Liver Pathology biopsy report

188

0.96

0.02

2.0

1.4

—

(3045788) Cell count panel - Pleural fluid

202

1.04

0.02

1.7

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

441

1.02

0.02

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

541

1.02

0.02

1.1

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

103

1.07

0.02

1.3

1.0

—

(3006462) Nitrate [Presence] in Urine

103

1.07

0.02

1.6

3.0

—

(4211845)

116

0.95

0.00

1.6

2.9

—

(3017704) Immunofixation for Urine

135

0.96

0.00

1.2

1.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

119

1.01

0.00

1.7

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

131

0.99

0.00

2.2

2.4

—

(3051651) Icteric interference index of Serum or Plasma

151

0.99

0.00

9.4

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

425

1.01

0.00

1.2

1.1

iu/ml

55.0

1283.5

—

105

(3016018) Differential panel - Cerebral spinal fluid

269

1.00

0.00

1.1

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

116

1.03

0.00

1.4

2.1

ug/l

22.9

290.0

0.67

103

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

366

1.01

0.00

1.0

u/ml

1.1

0.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

1033

1.00

0.00

1.7

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

117

1.03

0.00

1.5

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

117

1.03

0.00

1.5

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

223

0.99

0.00

1.6

1.5

e6/l

12107.8

103567.1

1.76

134

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

7.7

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.2

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.4

—

4.7

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

2923.3

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.02

0.00

1.2

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.2

—

2.9

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.2

—

57.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

14.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.2

—

66.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.99

0.00

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3051593) INR in Capillary blood by Coagulation assay

1.01

0.00

4.3

13.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.00

0.00

9.5

6.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.91

0.00

2.8

2.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.86

0.00

1.0

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.01

0.00

3.8

1.7

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.94

0.00

10.6

6.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.98

0.00

3.4

4.3

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.8

—

(4015189)

0.94

0.00

3.2

2.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1296.7

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_NOS	0.99 [0.86, 1.14]	0.892
Birth year	0.999 [0.99, 1.01]	0.747

During the follow-up period (1.1.1998 — 31.12.2019), 535 out of 7816 females with CD2_BENIGN_MELANOCYTIC_NOS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_NOS	0.989 [0.85, 1.15]	0.881
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 635 out of 5629 males with CD2_BENIGN_MELANOCYTIC_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_NOS.

N-year risk	Females	Males
1	0.105%	0.211%
5	0.691%	1.035%
10	1.699%	2.722%
15	3.148%	5.373%
20	5.272%	9.206%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_NOS – Melanocytic naevi, other sites/unspecified

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi, other sites/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints